Synthorx, Inc.. (THOR) NASDAQ

$67.99 0 (0.00%)

Market Cap: $2.20B

As of 01/22/20 12:00 AM EST. Market closed.

(THOR)

Synthorx, Inc.. (THOR) NASDAQ

$67.99 0 (0.00%)

Market Cap: $2.20B

As of 01/22/20 12:00 AM EST. Market closed.

Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, ... read more

Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
CEO Compensation (Base)
$430,125
CEO Compensation (Total)
$5.21M
URL
Address
.
Sector
Health Technology
Industry
Biotechnology
Full Time Employees
38
CEO Compensation (Base)
$430,125
CEO Compensation (Total)
$5.21M
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$67.99
Days Range
$0 - $0
52 week range
$11.05 - $71.90
Volume
0
Avg. Volume (30 days)
502,510
Market Cap
$2.20B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,338,000
Open
$0
Previous Close
$67.99
Days Range
$0 - $0
52 week range
$11.05 - $71.90
Volume
0
Avg. Volume (30 days)
502,510
Market Cap
$2.20B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
32,338,000

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SYNTHORX, INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Thompson Peter A. Director Jan 23, 2020 Option Exercise $68.00 5,316,355 361,512,140 0 Jan 24, 2020, 06:44 PM
Shawver Laura President and CEO Jan 23, 2020 Option Exercise $68.00 220,595 15,000,460 0 Jan 24, 2020, 06:41 PM
Shawver Laura President and CEO Jan 23, 2020 Option Exercise $68.00 25,000 1,700,000 0 Jan 24, 2020, 06:41 PM
Shah Pratik Director Jan 23, 2020 Option Exercise $68.00 62,412 4,244,016 0 Jan 24, 2020, 06:38 PM
Reardon Tighe Acting Chief Financial Officer Jan 23, 2020 Option Exercise $68.00 1,682,086 114,381,848 0 Jan 24, 2020, 06:36 PM
Reardon Tighe Acting Chief Financial Officer Jan 23, 2020 Option Exercise $68.00 43,688 2,970,784 0 Jan 24, 2020, 06:36 PM
Milla Marcos Chief Scientific Officer Jan 23, 2020 Option Exercise $68.00 63,989 4,351,252 0 Jan 24, 2020, 06:31 PM
Lichter Jay Director Jan 23, 2020 Option Exercise $68.00 1,682,086 114,381,848 0 Jan 24, 2020, 06:28 PM
Lichter Jay Director Jan 23, 2020 Option Exercise $68.00 448,567 30,502,556 0 Jan 24, 2020, 06:28 PM
Lichter Jay Director Jan 23, 2020 Option Exercise $68.00 150,000 10,200,000 0 Jan 24, 2020, 06:28 PM
Leveque Joseph Chief Medical Officer Jan 23, 2020 Option Exercise $68.00 316,164 21,499,152 0 Jan 24, 2020, 06:26 PM
Kolchinsky Peter Director Jan 23, 2020 Option Exercise $68.00 9,724,598 661,272,664 0 Jan 24, 2020, 06:23 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Jan 23, 2020 Option Exercise $68.00 9,724,598 661,272,664 0 Jan 24, 2020, 05:53 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Jan 23, 2020 Option Exercise $68.00 9,724,598 661,272,664 0 Jan 24, 2020, 05:11 PM
Leveque Joseph Chief Medical Officer Dec 30, 2019 Option Exercise $70.63 45,019 3,179,692 313,891 Jan 02, 2020, 04:43 PM
Leveque Joseph Chief Medical Officer Dec 30, 2019 Option Exercise $11.00 75,000 825,000 358,910 Jan 02, 2020, 04:43 PM
Milla Marcos Chief Scientific Officer Dec 30, 2019 Option Exercise $70.63 52,011 3,673,537 63,989 Jan 02, 2020, 04:41 PM
Milla Marcos Chief Scientific Officer Dec 30, 2019 Option Exercise $0.63 98,000 61,740 116,000 Jan 02, 2020, 04:41 PM
Shawver Laura President and CEO Dec 30, 2019 Option Exercise $70.63 210,010 14,833,006 296,301 Jan 02, 2020, 04:39 PM
Shawver Laura President and CEO Dec 30, 2019 Option Exercise $4.02 379,453 1,525,319 506,311 Jan 02, 2020, 04:39 PM
Shawver Laura President and CEO Jan 24, 2019 Option Exercise $0.63 25,000 15,750 25,000 Jan 25, 2019, 04:33 PM
Thompson Peter A. Director Dec 11, 2018 Buy $11.00 1,363,636 14,999,996 5,316,355 Dec 13, 2018, 06:37 PM
Reardon Tighe Acting Chief Financial Officer Dec 11, 2018 Buy $11.00 545,455 6,000,005 1,682,086 Dec 13, 2018, 06:36 PM
Lichter Jay Director Dec 11, 2018 Buy $11.00 545,455 6,000,005 1,682,086 Dec 13, 2018, 06:35 PM
ORBIMED ADVISORS LLC Director Dec 11, 2018 Buy $11.00 1,363,636 14,999,996 1,363,636 Dec 13, 2018, 06:33 PM
Kolchinsky Peter Director Dec 11, 2018 Buy $11.00 4,545,455 50,000,005 9,724,598 Dec 13, 2018, 06:31 PM
Avalon Ventures X, L.P. 10% Owner Dec 11, 2018 Buy $11.00 545,455 6,000,005 1,682,086 Dec 13, 2018, 06:30 PM
RA CAPITAL MANAGEMENT, LLC 10% Owner Dec 11, 2018 Buy $11.00 4,545,455 50,000,005 9,724,598 Dec 13, 2018, 06:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Thompson Peter A. Director 01/23/2020 361,512,140
Shawver Laura President and CEO 01/23/2020 15,000,460
Shawver Laura President and CEO 01/23/2020 1,700,000
Shah Pratik Director 01/23/2020 4,244,016
Reardon Tighe Acting Chief Financial Officer 01/23/2020 114,381,848
Reardon Tighe Acting Chief Financial Officer 01/23/2020 2,970,784
Milla Marcos Chief Scientific Officer 01/23/2020 4,351,252
Lichter Jay Director 01/23/2020 114,381,848
Lichter Jay Director 01/23/2020 30,502,556
Lichter Jay Director 01/23/2020 10,200,000
Leveque Joseph Chief Medical Officer 01/23/2020 21,499,152
Kolchinsky Peter Director 01/23/2020 661,272,664
RA CAPITAL MANAGEMENT, L.P. 10% Owner 01/23/2020 661,272,664
RA CAPITAL MANAGEMENT, L.P. 10% Owner 01/23/2020 661,272,664
Leveque Joseph Chief Medical Officer 12/30/2019 3,179,692
Leveque Joseph Chief Medical Officer 12/30/2019 825,000
Milla Marcos Chief Scientific Officer 12/30/2019 3,673,537
Milla Marcos Chief Scientific Officer 12/30/2019 61,740
Shawver Laura President and CEO 12/30/2019 14,833,006
Shawver Laura President and CEO 12/30/2019 1,525,319
Shawver Laura President and CEO 01/24/2019 15,750
Thompson Peter A. Director 12/11/2018 14,999,996
Reardon Tighe Acting Chief Financial Officer 12/11/2018 6,000,005
Lichter Jay Director 12/11/2018 6,000,005
ORBIMED ADVISORS LLC Director 12/11/2018 14,999,996
Kolchinsky Peter Director 12/11/2018 50,000,005
Avalon Ventures X, L.P. 10% Owner 12/11/2018 6,000,005
RA CAPITAL MANAGEMENT, LLC 10% Owner 12/11/2018 50,000,005
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2019
06/30/2019
0.31%
1Q

Period of Report: 09/30/2019

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2019
0.31%
1Q